Vertex’s Trikafta: Addressing Drug Pricing Issues

Original Article by Tamar Kahn | Business Day | 13 August 2025

Health activists highlight the issues with Vertex's Trikafta pricing and access, advocating for justice in cystic fibrosis care.

Health activists highlight the issues with Vertex’s Trikafta pricing and access, advocating for justice in cystic fibrosis care.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.

Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.

Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.